
Selda Samakoglu Md
I am a pediatric hematology and oncology specialist and a strategic thinker with a strong science and medical... | Swampscott, Massachusetts, United States
*50 free lookup(s) per month.
No credit card required.
Selda Samakoglu Md’s Emails se****@io****.com
Selda Samakoglu Md’s Phone Numbers No phone number available.
Social Media
Selda Samakoglu Md’s Location Swampscott, Massachusetts, United States
Selda Samakoglu Md’s Expertise I am a pediatric hematology and oncology specialist and a strategic thinker with a strong science and medical background in solid tumors, hematology-oncology, immunology, and inflammation, as well as strong business acumen. I have experience establishing drug/biologic clinical development protocols from Phase I to III, implementing sound regulatory and compliance strategies, and following good laboratory and clinical practices (GLP/GCP). I can rapidly comprehend scientific and clinical data and translate the underlying rationale into commercial opportunities, thereby adding value to the business. My experience includes supporting the development of the Portfolio Review and the ongoing processes to ensure current and accurate valuation of the Oncology pipeline, assessing the commercial potential of Business Development and Licensing (BD&L) opportunities, and providing commercial support for products in the early stages of development. I am a decisive project and team leader with high-powered drive and execution, managing multi-million project budgets, known for leading by example and conveying a sense of urgency to fulfill multiple time-sensitive project timelines. Successfully build an external scientific and medical network to enable the implementation of innovative clinical and personalized medicine strategies in clinical development programs to enhance benefits for patients and the probability of successful product registration and commercialization. Agile learner, keen on tracking and understanding the latest industry trends in precision medicine and empowering and nurturing a creative and collaborative workplace
Selda Samakoglu Md’s Current Industry Iovance Biotherapeutics
Selda
Samakoglu Md’s Prior Industry
Institute Pasteur Paris
|
Genethon Centre
|
Memorial Sloan Kettering Cancer Center
|
Weill Cornel Medical College
|
Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly
|
Gilead Sciences
|
Boehringer Ingelheim
|
Pharmacyclics
|
Bristol Myers Squibb
|
Csl Behring Early Clinical Development Program Inherited Forms Of Anemias Thrombosis
|
Replimune
|
Iovance Biotherapeutics
Not the Selda Samakoglu Md you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Iovance Biotherapeutics
Executive Director, Clinical Development, Oncology
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Replimune
Senior Director, Clinical Development, Oncology
Fri May 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Csl Behring Early Clinical Development Program Inherited Forms Of Anemias Thrombosis
Director, Early Clinical and Translational Development
Thu Nov 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri May 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
Director, Clinical and Translational Medicine, Lead of Hematology-Oncology Franchises
Mon May 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Nov 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Pharmacyclics
Director, Lead of Translational Medicine-Oncology
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon May 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Boehringer Ingelheim
Director, Early Clinical and Translational Medicine Expert, Oncology
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Aug 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Gilead Sciences
Senior Clinical Biomarker Lead of Biology-Biomarkers
Fri Jun 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Feb 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly
Principal Scientist, Head of pharmacodynamic biomarkers and mechanism of action group
Mon Feb 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly
Senior Scientist III
Fri Feb 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Feb 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Weill Cornel Medical College
Assistant Professor
Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Feb 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Memorial Sloan Kettering Cancer Center
Principal Investigator
Tue Jan 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Genethon Centre
Visiting Research Fellow
Sat Jan 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Institute Pasteur Paris
Post Doctoral Research Fellow
Fri Jan 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time)